ARROGENE, INC: 10-Q filed 2013-09-16

Name: ARROGENE, INC: 10-Q filed 2013-09-16
Creator: ARROGENE, INC
License: https://creativecommons.org/licenses/by/4.0/

What ARROGENE, INC reported in its quarterly report filed 2013-09-16 (fiscal Q3 2013): 22 published measures, 79 facts as tagged in accession 0001376474-13-000470.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-09-16
Fiscal period: fiscal Q3 2013
Accession: 0001376474-13-000470 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ARROGENE, INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-07-31	203,905	USD
At 2012-10-31	556,018	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-07-31	294,293	USD
At 2012-10-31	89,593	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-07-31	-90,388	USD
At 2012-10-31	466,425	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-07-31	181,386	USD
At 2012-10-31	539,727	USD
At 2012-07-31	636,709	USD
At 2011-10-31	2,094	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-280,669	USD	92
2012-11-01 to 2013-07-31	-784,458	USD	273
2007-08-07 to 2013-07-31	-4,379,812	USD	2186
2011-11-01 to 2012-10-31	-2,073,490	USD	366
2012-05-01 to 2012-07-31	-222,720	USD	92
2011-11-01 to 2012-07-31	-1,866,756	USD	274
2010-11-01 to 2011-10-31	-990,817	USD	365
2009-11-01 to 2010-10-31	-360,208	USD	365
2008-11-01 to 2009-10-31	-168,756	USD	365
2007-11-01 to 2008-10-31	-868	USD	366
2007-08-07 to 2007-10-31	-1,215	USD	86

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-11-01 to 2013-07-31	-585,986	USD	273
2007-08-07 to 2013-07-31	-2,345,515	USD	2186
2011-11-01 to 2012-07-31	-940,226	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-11-01 to 2013-07-31	227,645	USD	273
2007-08-07 to 2013-07-31	2,141,910	USD	2186
2011-11-01 to 2012-07-31	1,186,607	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2007-08-07 to 2013-07-31	384,991	USD	2186
2011-11-01 to 2012-07-31	388,234	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-07-31	-4,379,812	USD
At 2012-10-31	-3,595,354	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-07-31	2,097	USD
At 2012-10-31	3,271	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2007-08-07 to 2013-07-31	273,680	USD	2186
2011-11-01 to 2012-07-31	22,400	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	-280,391	USD	92
2012-11-01 to 2013-07-31	-783,897	USD	273
2007-08-07 to 2013-07-31	-3,500,062	USD	2186
2012-05-01 to 2012-07-31	-222,636	USD	92
2011-11-01 to 2012-07-31	-1,109,507	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-07-31	201,808	USD
At 2012-10-31	552,747	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	278	USD	92
2012-11-01 to 2013-07-31	561	USD	273
2007-08-07 to 2013-07-31	879,750	USD	2186
2012-05-01 to 2012-07-31	84	USD	92
2011-11-01 to 2012-07-31	757,249	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-07-31	294,293	USD
At 2012-10-31	89,593	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	280,391	USD	92
2012-11-01 to 2013-07-31	783,897	USD	273
2007-08-07 to 2013-07-31	3,500,062	USD	2186
2012-05-01 to 2012-07-31	222,636	USD	92
2011-11-01 to 2012-07-31	1,109,507	USD	274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	147,799	USD	92
2012-11-01 to 2013-07-31	466,813	USD	273
2007-08-07 to 2013-07-31	2,603,999	USD	2186
2012-05-01 to 2012-07-31	190,386	USD	92
2011-11-01 to 2012-07-31	567,895	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-05-01 to 2013-07-31	132,592	USD	92
2012-11-01 to 2013-07-31	317,084	USD	273
2007-08-07 to 2013-07-31	415,633	USD	2186
2012-05-01 to 2012-07-31	32,250	USD	92
2011-11-01 to 2012-07-31	61,182	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-07-31	21,350,860	shares
At 2012-10-31	21,090,860	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-07-31	4,287,289	USD
At 2012-10-31	4,059,670	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2013-07-31	-90,388	USD
At 2012-10-31	466,425	USD
At 2011-10-31	-1,022,287	USD
At 2010-10-31	-165,703	USD
At 2009-10-31	-169,743	USD
At 2008-10-31	-987	USD
At 2007-10-31	-119	USD
At 2007-08-06	1,096	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-11-01 to 2013-07-31	1,174	USD	273
2007-08-07 to 2013-07-31	2,600	USD	2186
2011-11-01 to 2012-07-31	528	USD	274

Inspect the source

Entity: ARROGENE, INC / CIK 0001403792
Captured: 2026-09-23 02:52 UTC
SEC response SHA-256: e9c8c3a7f77b1fda5c670b336964f271e208cc4ac5926c5ea0b29419f435a588

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001403792.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))